Chemistry: molecular biology and microbiology – Measuring or testing process involving enzymes or... – Involving nucleic acid
Patent
1997-12-04
1999-04-27
Scheiner, Toni R.
Chemistry: molecular biology and microbiology
Measuring or testing process involving enzymes or...
Involving nucleic acid
435 72, 435 723, 436 63, 436 64, G01N 33574, G01N 3353, C12Q 168
Patent
active
058979913
ABSTRACT:
Disclosed is a method of detecting malignancy in a body cavity effusion. Also disclosed is a method of distinguishing a benign hyperplastic lymph node from a lymph node involved by a low grade follicular lymphoma. Also disclosed is a method of distinguishing a benign tumor from a malignant tumor which overexpresses GLUT-1.
REFERENCES:
patent: 5698410 (1997-12-01), Burstein et al.
Y. Noguchi, et al., "Expression of Glucose Transporters and Insulin Resistance in Human GI Cancer," Proceedings of the American Association for Cancer Research, 36:205 (Mar. 1995).
M. Younes, et al., "Most Non-Small Cell Lung Cancers (LCA) Express the Human Erythrocyte Glucose," Proceedings of the American Association for Cancer Research, 36:249 (Mar. 1995).
G. Boden, et al., "Glucose Transporter Proteins in Human Insulinoma," Annals. of Internal Medicine, 121 (2) :109-112 (Jul. 1994).
R. S. Brown, and R. L. Wahl, "Overexpression of Glut-1 Glucose Transporter in Human Breast Cancer," Cancer, 72 (10) :2979-2985 (Nov. 1993).
P. Mellanen, et al., "Expression of Glucose Transporters in Head-and-Neck Tumors," Int. J. Cancer, 56:622-629 (1994).
Y. Nagase, et al., "Immunohistochemical Localization of Glucose Transporters in Human Renal Cell Carcinoma," The Journal of Urology, 153:798-801 (Mar. 1995).
T. Yamamoto, et al., "Over-Expression of Facilitative Glucose Transporter Genes in Human Cancer," Biochemical and Biophysical Research Communications, 170 (1) :223-230 (1990).
R. S. Brown, et al., "Intratumoral Distribution of Tritiated-FDG in Breast Carcinoma: Correlation between Glut-1 Expression and FDG Uptake," The Journal of Nuclear Medicine, 37(6) :1042-1047 (Jun. 1996).
D. Kornrumpf, et al., "Overexpression of Glut-1 Glucose Transporter in Human Pancreatic Cancer--An Immunohistochemical Study," The Journal of Nuclear Medicine, 36(5) :211P Proceedings of the 42 Annual Meeting (May 1995), Abstract.
S. Nagamatsu, et al., "Expression of Facilitative Glucose Transporter Isoforms in Human Brain Tumors," Journal of Neurochemistry, 61 (6) :2048-2053 (Dec. 1993).
T. Higashi, et al., "Overexpression of GLUT-1 Glucose Transporter in Human Malignant Pancreatic Tumors Immunohistochemical Study of Glucose-1,2,3,4 and 5 Glucose Transporters," Gastroenterology, 110 (4) :A528 (Apr. 1996), Abstract.
M. Younes, et al., "Glucose Transporter Glut 1 is Frequently Expressed in Colon Cancer," U.S. Canadian Acad. Pathology 1995 Meeting, Mar. 11-19, p. 71A, Abstract No. 404 (1995).
S. Baer et al., Expression of Glut1 and Glut3 in Squamous Cell Carcinomas of the Head and Neck (SCCNHN), Laboratory Investifation 76:113A (1997) Annual Meeting Abstracts, Abstract.
M. Younes, et al., "Glut1 and Glut3 Are Significant Prognostic Indicators in State I Non-Small Cell Lung Carcinoma," Laboratory Investigation 74:165A (1996) Annual Meeting Abstracts, Abstract.
Juarez et al., "Glut1 Expression in Transitional Cell Carcinoma of the Urinary Bladder Correlates with Agressive Biologic Behavior," Laboratory Investigation 74:75A (1996), Annual Meeting Abstracts, Abstract.
Burstein David E.
Haber Richard S.
Scheiner Toni R.
The Mount Sinai Medical Center
LandOfFree
Highly sensitive immunocytochemical method for diagnosis of mali does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Highly sensitive immunocytochemical method for diagnosis of mali, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Highly sensitive immunocytochemical method for diagnosis of mali will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-685497